Collegium Pharmaceutical (COLL) Treasury Shares (2014 - 2026)

Collegium Pharmaceutical's Treasury Shares history runs 9 years deep, the most recent figure standing at $222.5 million for Q1 2026.

• In Q1 2026, Treasury Shares rose 12.66% year-over-year to $222.5 million; the TTM figure through Mar 2026 stood at $222.5 million (up 12.66% YoY), while the FY2025 annual figure was $222.5 million, up 12.66% from the prior year.
• Treasury Shares was $222.5 million for Q1 2026 at Collegium Pharmaceutical, roughly flat from $222.5 million in the prior quarter.
• In the past five years, Treasury Shares ranged from a high of $9.0 million in Q3 2025 to a low of $173659.0 in Q3 2024.
• Historically, Treasury Shares has averaged $5.5 million across 5 years, with a median of $6.3 million in 2023.
• The sharpest annual moves came in 2022 and 2025: Treasury Shares soared 210.54% in 2022, then climbed 12.66% in 2025.
• A 5-year view of Treasury Shares shows it stood at $61.9 million in 2022, then soared by 121.85% to $137.4 million in 2023, then surged by 43.76% to $197.5 million in 2024, then rose by 12.66% to $222.5 million in 2025, then changed by 0.0% to $222.5 million in 2026.
• The last three Treasury Shares figures came in at $222.5 million (Q1 2026), $222.5 million (Q4 2025), and $222.5 million (Q3 2025), per Business Quant data.